Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia reels in another $23M in financing

Proscia
By Author Proscia | December 2, 2020

Digital pathology company Proscia has raised $23 million in a series B financing round, bringing its total funding to $35 million.

The company said it plans to use the new funding to accelerate global development and the reach of its Concentriq software program, ramping up sales and marketing and satisfying increasing demand for digital pathology solutions.

Our website uses cookies. By using this site, you agree to its use of cookies.